Candela to Surpass Analysts' Estimates
WAYLAND, Mass.--(BW HealthWire)--Oct. 12, 1999--Candela Corporation (NASDAQ:CLZR - news), a leading developer of aesthetic laser systems, announced today that its September quarter beat analysts' estimates for both revenues and profits. Commenting on the quarter, Gerard E. Puorro, Candela's President and Chief Executive Officer said: ``The first quarter of our fiscal year surpassed even our own estimates. We are especially delighted that we saw continued strong growth across all of our markets during the summer months, which is traditionally the industry's slowest period.'
The company will announce its full first quarter results on October 21, 1999.
About Candela
Candela Corporation develops, manufactures, and distributes innovative clinical solutions that enable physicians, surgeons and personal care practitioners to treat selected cosmetic and medical conditions using lasers, cryosurgery and other proven technologies. Founded near Boston in 1970, Candela markets and services its products in over 40 countries from offices in the United States, Europe and Asia. Candela established the aesthetic laser market 11 years ago. With an installed base of over 2,000 lasers worldwide, more than 500,000 aesthetic laser procedures are performed annually with Candela laser systems. For more information about Candela, visit the company's web site at clzr.com. |
